The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 196K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schuh, K.
Right arrow Articles by Serfling, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuh, K.
Right arrow Articles by Serfling, E.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1998/10/1369/ $5.00
The Journal of Experimental Medicine, Volume 188, Number 7, October 5, 1998 1369-1373


Brief Definitive Reports

The Interleukin 2 Receptor {alpha} Chain/CD25 Promoter Is a Target for Nuclear Factor of Activated T Cells

Kai Schuh*, Thomas Twardzik*, Burkhard Kneitz{ddagger}, Jörg Heyer*, Anneliese Schimpl{ddagger}, and Edgar Serfling*

From the * Institute of Pathology, and the {ddagger} Institute of Virology and Immunobiology, University of Würzburg, D-97080 Würzburg, Germany

The expression of the murine interleukin (IL)-2 receptor {alpha} chain/CD25 is strongly induced at the transcriptional level after T cell activation. We show here that nuclear factor of activated T cell (NF-AT) factors are involved in the control of CD25 promoter induction in T cells. NF-ATp and NF-ATc bind to two sites around positions –585 and –650 located upstream of the proximal CD25 promoter. Immediately 3' from these NF-AT motifs, nonconsensus sites are located for the binding of AP-1–like factors. Mutations of sites that suppress NF-AT binding impair the induction and strong NF-ATp–mediated transactivation of the CD25 promoter in T cells. In T lymphocytes from NF-ATp–deficient mice, the expression of CD25 is severely impaired, leading to a delayed IL-2 receptor expression after T cell receptor (TCR)/CD3 stimulation. Our data indicate an important role for NF-AT in the faithful expression of high affinity IL-2 receptors and a close link between the TCR-mediated induction of IL-2 and IL-2 receptor {alpha} chain promoters, both of which are regulated by NF-AT factors.

Key Words: interleukin 2 receptor • nuclear factor of activated T cells • transcription factors • T cells • NF-AT factors


Address correspondence to Edgar Serfling, Department of Molecular Pathology, Institute of Pathology, University of Würzburg, Josef-Schneider-Str. 2, D-97080 Würzburg, Germany. Phone: 49-931-201-34-29/95; Fax: 49-931-201-34-40; E-mail: path015{at}mail.uni-wuerzburg.de

The first two authors contributed equally to this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS